diabetes type 2 - Nursing Case Study

Pathophysiology

• Primary mechanism: Insulin resistance - Peripheral tissues, notably muscle and adipose, exhibit reduced sensitivity to insulin, impairing glucose uptake, leading to persistent hyperglycemia. This resistance is largely influenced by genetic factors, obesity, and physical inactivity, causing pancreatic beta cells to compensate by overproducing insulin.

• Secondary mechanism: Beta-cell dysfunction - Chronic insulin resistance leads to beta-cell exhaustion and failure. Over time, the pancreatic beta cells cannot sustain increased insulin output, resulting in declining insulin production and further exacerbating hyperglycemia.

• Key complication: Chronic hyperglycemia - Persistent high blood glucose levels contribute to microvascular damage (retinopathy, nephropathy, neuropathy) and macrovascular complications (cardiovascular disease), significantly impacting morbidity and mortality in individuals with type 2 diabetes.

Patient Profile

Demographics:

58-year-old male, retired construction worker

History:

• Key past medical history: Diagnosed with type 2 diabetes 15 years ago, history of hypertension, chronic kidney disease stage 3, diabetic neuropathy, and retinopathy

• Current medications: Metformin, Lisinopril, Insulin glargine, Atorvastatin, Gabapentin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe fatigue and shortness of breath

• Key symptoms: Persistent hyperglycemia, polyuria, peripheral edema, blurred vision, numbness in feet, and chest discomfort

• Vital signs: Blood pressure 180/110 mmHg, heart rate 112 bpm, respiratory rate 24 breaths per minute, temperature 98.6°F, oxygen saturation 89% on room air, blood glucose level 320 mg/dL

Section 1

New Diagnostic Results:

Following the initial presentation, the healthcare team conducted a series of diagnostic tests to further evaluate the patient's condition. The lab results revealed significant findings: his hemoglobin A1c level was critically high at 10.5%, indicating poor long-term glycemic control. An echocardiogram showed signs of left ventricular hypertrophy, a consequence of prolonged hypertension and increased cardiovascular strain. Additionally, a chest X-ray indicated mild pulmonary edema, correlating with his symptoms of shortness of breath and peripheral edema, suggesting the possibility of congestive heart failure exacerbation.

Renal function tests displayed a concerning trend, with serum creatinine elevated at 2.2 mg/dL and estimated glomerular filtration rate (eGFR) declining to 45 mL/min/1.73 m², indicative of worsening chronic kidney disease. Urinalysis showed significant proteinuria, further emphasizing renal impairment. Moreover, an electrocardiogram (ECG) demonstrated sinus tachycardia with nonspecific ST-T wave changes, raising suspicion for ischemic changes possibly related to his reported chest discomfort.

These diagnostic findings necessitate urgent clinical reasoning and intervention. The combination of cardiac, renal, and diabetes-related complications highlights the need for a multidisciplinary approach to manage his complex condition. The healthcare team must prioritize optimizing blood pressure control, improving glycemic management, and addressing potential heart failure to prevent further deterioration.

Section 2

Change in Patient Status:

Shortly after the diagnostic results were reviewed, the patient's condition began to deteriorate. During a routine check, the nurse noted an increase in the patient's respiratory rate to 28 breaths per minute, with accompanying use of accessory muscles, indicating worsening respiratory distress. His blood pressure was elevated at 168/98 mmHg, and his heart rate remained persistently tachycardic at 115 beats per minute. Auscultation of the lungs revealed bilateral crackles, more pronounced at the bases, suggesting progression of pulmonary congestion. The patient's oxygen saturation dropped to 88% on room air, necessitating supplemental oxygen via nasal cannula.

The patient also reported increasing fatigue and dizziness upon minimal exertion, which raised concerns about declining cardiac output and possible exacerbation of heart failure. Laboratory tests showed a further increase in serum creatinine to 2.4 mg/dL, with eGFR decreasing to 42 mL/min/1.73 m², indicating rapid progression of renal impairment. Meanwhile, a repeat ECG showed more pronounced ST depression in the lateral leads, heightening the suspicion of ongoing ischemic changes. Despite the initiation of diuretics to manage fluid overload, the patient's urine output remained low, suggesting worsening renal function and resistance to current interventions.

Faced with these developments, the healthcare team must urgently reassess the therapeutic strategy. There is a pressing need to optimize diuretic therapy, reconsider the current cardiovascular medications, and possibly initiate renal replacement therapy if renal function continues to decline. The complexity of managing the interplay between heart failure, renal impairment, and poorly controlled diabetes requires a coordinated approach to adjust the treatment plan promptly. This situation calls for critical thinking to balance interventions that address each organ system's needs without exacerbating other complications, as the patient's journey becomes increasingly precarious.

Section 3

Response to Interventions:

In response to the patient's deteriorating condition, the healthcare team initiated a more aggressive management approach. Furosemide was administered intravenously at a higher dose to enhance diuresis, while the patient's fluid status was meticulously monitored. Despite these efforts, the patient's urine output remained scant, and signs of fluid retention persisted. In light of the refractory fluid overload and worsening renal function, the nephrology team was consulted for potential initiation of renal replacement therapy. The decision to start continuous renal replacement therapy (CRRT) was made to manage the patient's acute kidney injury and fluid overload while minimizing hemodynamic instability.

In addition to renal management, the cardiology team adjusted the patient's cardiovascular medications. An ACE inhibitor was cautiously introduced to improve cardiac output and manage hypertension, recognizing the need to carefully balance its renal effects. The patient's beta-blocker dose was reassessed, considering the ongoing tachycardia and ischemic changes on the ECG. Meanwhile, supplemental oxygen was increased to maintain adequate oxygenation, and the patient's clinical status was closely monitored for any signs of respiratory or hemodynamic compromise.

Over the next 24 hours, the patient showed some signs of stabilization. Urine output gradually improved with the initiation of CRRT, and there was a modest reduction in pulmonary congestion, as evidenced by clearer lung sounds upon auscultation. The patient's oxygen saturation improved to 92% with supplemental oxygen, and his respiratory rate decreased to 22 breaths per minute. However, the healthcare team remained vigilant for potential complications, including electrolyte imbalances and infection risks associated with renal replacement therapy. This ongoing complexity required continuous reassessment and adjustment of the treatment plan, emphasizing the critical need for interdisciplinary collaboration and advanced clinical judgment as the patient's condition continued to evolve.

Section 4

In the following 48 hours, the patient's clinical status began to shift, presenting new challenges that required swift and precise clinical reasoning. Despite initial stabilization, the patient developed new complications, notably an electrolyte imbalance. Laboratory results indicated a significant drop in serum potassium levels to 2.8 mEq/L, raising concerns for potential cardiac arrhythmias. Concurrently, the patient's magnesium level was also noted to be low at 1.4 mg/dL, compounding the risk for ventricular dysrhythmias. These imbalances were likely exacerbated by the aggressive diuresis and renal replacement therapy, necessitating prompt correction.

The healthcare team, recognizing the critical nature of these findings, initiated intravenous potassium and magnesium replacements, adhering to a carefully titrated protocol to avoid rapid shifts that could destabilize the patient further. Continuous cardiac monitoring was established to detect any emergent arrhythmias, and serial electrolyte measurements were ordered to guide ongoing replacement therapy. Meanwhile, the patient's blood glucose levels began to exhibit erratic fluctuations, with episodes of both hyperglycemia and hypoglycemia, complicating the management of his type 2 diabetes. This prompted an endocrinology consult to optimize the patient's insulin regimen and address potential insulin resistance issues linked with the acute stress response and underlying infection risk.

As the patient journeyed through this complex phase, the interdisciplinary team remained acutely aware of the potential for cascading complications. The risk of infection from prolonged CRRT and vascular access was high, necessitating meticulous aseptic techniques and vigilant monitoring for signs of sepsis. This evolving scenario underscored the necessity for advanced clinical judgment, as each intervention carried the potential for further complications. The team's ability to anticipate, recognize, and respond to these dynamic changes would be crucial in guiding the patient toward recovery and preventing further deterioration.

Section 5

The next morning, the healthcare team assembled to review the most recent developments in the patient's condition. The initial assessment revealed a concerning change in the patient's neurological status. The patient, who had previously been alert and oriented, was now exhibiting confusion and disorientation. Vital signs indicated a blood pressure of 95/60 mmHg, heart rate of 110 bpm with occasional premature ventricular contractions noted on the cardiac monitor, and a respiratory rate of 24 breaths per minute with shallow breathing. The temperature was 101.2°F, suggesting a possible infectious process. The patient’s skin was cool and clammy, and capillary refill time was delayed, raising concerns about perfusion and potential circulatory compromise.

New diagnostic results compounded the complexity of the case. Blood cultures obtained 24 hours prior returned positive for a gram-negative organism, indicating a bloodstream infection likely secondary to the central venous catheter used for continuous renal replacement therapy. The white blood cell count had spiked to 18,000/mm³, and lactic acid levels were elevated at 3.8 mmol/L, suggesting impending septic shock. Despite ongoing electrolyte replacement, the patient’s potassium remained suboptimal at 3.1 mEq/L, and magnesium was marginally improved at 1.6 mg/dL. Additionally, a follow-up ECG showed prolonged QT intervals, raising the stakes for torsades de pointes amidst the electrolyte derangements.

The response to these interventions required the team to recalibrate their approach swiftly. Broad-spectrum antibiotics were initiated immediately, and the decision was made to replace the central line under strict sterile conditions to mitigate the infection source. Fluid resuscitation was carefully titrated to improve hemodynamic stability without exacerbating potential pulmonary congestion. The endocrinologist adjusted the insulin regimen, opting for a continuous insulin infusion to better manage the labile glucose levels. This critical juncture demanded astute clinical reasoning to prioritize interventions while vigilantly monitoring for any signs of deterioration, setting the stage for the next phase of the patient's complex recovery journey.